Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1036 of 6351
-
New program tackles depression and HIV together in rural zimbabwe
Disease control CompletedA hybrid effectiveness-efficacy trial to evaluate a stepped care task shifted intervention to treat depression and HIV medication nonadherence in low resource settings in rural Zimbabwe.
Sponsor: King's College London • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
One pill before radiation: a new shield for bones?
Disease control CompletedThis is a double blind randomized controlled study investigating the efficacy of a single dose of 150 mg risedronate (a bone anti-resorptive) vs a single dose of placebo given prior to SBRT for peripheral lung tumors that are within 2 cm of the chest wall. Our hypothesis is that …
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a temporary stent keep leg arteries open?
Disease control OngoingThe purpose of this study is to evaluate the performance and safety of the Temporary Spur Stent System (TSS). The TSS is intended for use in conjunction with a commercially available drug coated balloon in the infrapopliteal arteries for the treatment of de novo or restenotic les…
Sponsor: ReFlow Medical, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for rare blistering disease: rituximab vs standard therapy
Disease control OngoingMucous membrane pemphigoid (MMP) describes a group of chronic auto-immune bullous diseases (AIBD) of the basement membrane zone (BMZ), characterized by predominant or exclusive mucosal involvement, including oral, naso-pharyngeal, laryngo-tracheal, genital, oesophageal, anal and …
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Brain pacemaker that learns: new trial aims to personalize Parkinson's treatment
Disease control By invitation onlyThis study involves patients who are already planning to have deep brain stimulation (DBS) surgery to treat the symptoms of severe Parkinson's Disease (PD). The study has two goals: 1. to evaluate the effectiveness of implanting DBS electrodes in the two most common locations fo…
Sponsor: Dennis Turner, M.D. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New pill shows promise against tough lung cancer
Disease control OngoingThis study will treat patients with advanced NSCLC with EGFR or HER2 mutation who have progressed following prior therapy. This is the first time this drug is tested in patients, and so it will help to understand what type of side effects may occur with the drug treatment. It wil…
Phase 1/2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a lower dose of cyclophosphamide make stem cell transplants less risky?
Disease control OngoingBackground: Stem cell or bone marrow transplants can cure or control blood cancers. Sometimes the donor cells see the recipient's body as foreign. This can cause complications. A high dose of the drug cyclophosphamide (PTCy) can help reduce these risks. Researchers want to see i…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Promising new drug combo gives hope for kids with relapsed neuroblastoma
Disease control OngoingThis phase II trial studies how well irinotecan hydrochloride, temozolomide, and dinutuximab work with or without eflornithine in treating patients with neuroblastoma that has come back (relapsed) or that isn't responding to treatment (refractory). Drugs used in chemotherapy, suc…
Phase 2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a common diabetes pill prevent dangerous pregnancy complications?
Prevention CompletedAlthough major advancements have been made in improving glycemic management in type 1 diabetes mellitus (DM), women entering pregnancy with type 1 DM continue to be at dramatically increased risk for adverse maternal and neonatal outcomes, including hypertensive disorders of preg…
Phase 4 • Sponsor: Maisa N. Feghali, MD • Aim: Prevention
Last updated Aug 26, 2026 00:00 UTC
-
Experimental gene therapy aims to fix cystinosis at the source
Disease control CompletedThis study is a Phase 1/2 clinical trial that will assess the safety and efficacy of enriched gene-corrected hematopoietic stem cells isolated from patients affected with cystinosis. (Investigational Product: CTNS-RD-04, including product manufactured with and without the transdu…
Phase 1/2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for Hard-to-Treat breast cancer: immune cocktails enter trial
Disease control OngoingThis phase II trial studies how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the combination of avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage IV or is not able to be r…
Phase 2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for recurrent rectal cancer: adding radiation before surgery may boost cure rates
Disease control CompletedGRECCAR 15 is focused on Locally Recurrent Rectal Cancer (LRRC) for patients with previous pelvic radiotherapy for the primary rectal cancer. This situation leads to a 20% higher risk of non-curative resection for the LRRC management (R1 status) impacting significantly the overal…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a new nerve block beat standard pain relief for shoulder surgery?
Symptom relief CompletedArthroscopic shoulder surgery is a common and minimally invasive procedure utilized for different shoulder pathologies, but it is often associated with moderate to severe postoperative pain that may interfere with patients' well-being and course of recovery. By using an effective…
Sponsor: McMaster University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Could group checkups for pregnant women reduce preterm births?
Prevention CompletedIn this study, we test the effectiveness of an evidence-based model of group antenatal care by comparing it to individual (usual) antenatal care (Aim 1) across 7 antenatal clinics in Blantyre District, Malawi. If results are negative, governments will avoid spending on ineffectiv…
Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jul 15, 2026 00:00 UTC
-
New device could help stroke patients recover hand function faster
Disease control CompletedStroke is a major cause of adult long term disability and the fourth leading cause of death and affects 1·8/1000 persons in Singapore. Post-stroke functional recovery of upper limb is poor with 80% of stroke survivors having some upper limb disability during the acute to subacute…
Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a pill replace chemo for some breast cancer patients?
Disease control OngoingThe study investigates, whether the patient group with intermediate-risk early breast cancer benefits from treatment with ribociclib in combination with endocrine therapy compared to standard-of-care chemotherapy (followed by adjuvant endocrine therapy).
Phase 3 • Sponsor: West German Study Group • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Steroid shot during surgery may cut cancer recovery risks
Disease control OngoingPerioperative inflammation is harmful in cancer patients, namely in those undergoing surgery: it increases the risk of recurrence, decreases cancer survival, increases post-operative complications, and prolongs the time of recovery and the duration of hospital stay. Severe postop…
Phase 3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo shows promise for aggressive lymphoma patients
Disease control OngoingThis is a prospective, multicenter, single arm, phase II trial in patients with ≥ 18 and \<65 years with poor-prognosis (IPI ≥ 2) and newly diagnosed ABC-DLBCL. Aim of the study is to assess the efficacy and the safety of R-CHOP in combination with ibrutinib for 6 cycles followe…
Phase 2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Experimental CAR t therapy targets two cancers at once
Disease control Recruiting nowThis is a phase I, interventional, single arm, open label, treatment study to evaluate the safety and tolerability of BCMA-CD19 cCAR in patients with relapsed and/or refractory multiple myeloma and plasmacytoid lymphoma.
Phase 1 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 18:30 UTC
-
Wearable eye-tracker aims to catch dizziness in the act
Diagnosis CompletedClinical investigation of a medical device (CAVA) for recording eye movements. Patients suffering from diagnosed dizziness conditions will wear the device for 23 hours a day, for 30 days. The device will capture normal eye movement data as well as data corresponding to any dizzy …
Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC